Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adri C Voogd

Showing results (121-130 of 159) with videos related to

Pageof 16
Sort By:
Nuclear Medicine Communications|February 26, 2026
The proportion, clinical predictors, and prognostic impact of hypometabolic estrogen receptor-positive primary breast cancer on baseline [18F] fluorodeoxyglucose PETMelissa Lenaerts, Lois van der Voort, Marjolein L Smidt, et al.
Oncotarget|January 12, 2017
The correlation of age with chemotherapy-induced ovarian function failure in breast cancer patientsIngeborg J H Vriens, Ashley J R De Bie, Maureen J B Aarts, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 24, 2009
P21 Cip1/WAF1 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosisHarriët C Hafkamp, Jeroen J Mooren, Sandra M H Claessen, et al.
Oncotarget|November 8, 2017
Cost and cost-effectiveness of adjuvant trastuzumab in the real world setting: A study of the Southeast Netherlands Breast Cancer ConsortiumShanly C Seferina, Bram L T Ramaekers, Maaike de Boer, et al.
International Journal of Cancer|April 20, 2019
Trends in frequency and outcome of high-risk breast lesions at core needle biopsy in women recalled at biennial screening mammography, a multiinstitutional studyJacky D Luiten, Bram Korte, Adri C Voogd, et al.
European Journal of Cancer (Oxford, England : 1990)|April 30, 2025
Overall survival of patients with de Novo HER2-positive metastatic breast cancer in the Netherlands from 2008 to 2017: A population-based cohort study of systemically treated patientsNan Ding, Karlijn E P E Hermans, Thiemo J A van Nijnatten, et al.
Breast (Edinburgh, Scotland)|November 17, 2009
Factors contributing to improved local control after mastectomy in patients with breast cancer aged 40 years or youngerElke J R Lammers, Paulien Huibers, Maurice J C van der Sangen, et al.
Breast Cancer Research and Treatment|January 30, 2017
Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancersMarc B I Lobbes, Ingeborg J H Vriens, Annelotte C M van Bommel, et al.
The Lancet Regional Health. Europe|December 1, 2025
Frequency and survival of delayed breast cancer diagnosis in women participating at screening mammography in the Netherlands: a population-based studyLucien E M Duijm, Eline L van der Veer, Hermen C van Beek, et al.
Journal of Surgical Oncology|July 25, 2019
Predicting the extent of nodal involvement for node positive breast cancer patients: Development and validation of a novel toolIngrid van den Hoven, David van Klaveren, Nicole C Verheuvel, et al.
Pageof 16

Showing results (121-130 of 159) with videos related to

Sort By:
Pageof 16
Nuclear Medicine Communications|February 26, 2026
The proportion, clinical predictors, and prognostic impact of hypometabolic estrogen receptor-positive primary breast cancer on baseline [18F] fluorodeoxyglucose PETMelissa Lenaerts, Lois van der Voort, Marjolein L Smidt, et al.
Oncotarget|January 12, 2017
The correlation of age with chemotherapy-induced ovarian function failure in breast cancer patientsIngeborg J H Vriens, Ashley J R De Bie, Maureen J B Aarts, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 24, 2009
P21 Cip1/WAF1 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosisHarriët C Hafkamp, Jeroen J Mooren, Sandra M H Claessen, et al.
Oncotarget|November 8, 2017
Cost and cost-effectiveness of adjuvant trastuzumab in the real world setting: A study of the Southeast Netherlands Breast Cancer ConsortiumShanly C Seferina, Bram L T Ramaekers, Maaike de Boer, et al.
International Journal of Cancer|April 20, 2019
Trends in frequency and outcome of high-risk breast lesions at core needle biopsy in women recalled at biennial screening mammography, a multiinstitutional studyJacky D Luiten, Bram Korte, Adri C Voogd, et al.
European Journal of Cancer (Oxford, England : 1990)|April 30, 2025
Overall survival of patients with de Novo HER2-positive metastatic breast cancer in the Netherlands from 2008 to 2017: A population-based cohort study of systemically treated patientsNan Ding, Karlijn E P E Hermans, Thiemo J A van Nijnatten, et al.
Breast (Edinburgh, Scotland)|November 17, 2009
Factors contributing to improved local control after mastectomy in patients with breast cancer aged 40 years or youngerElke J R Lammers, Paulien Huibers, Maurice J C van der Sangen, et al.
Breast Cancer Research and Treatment|January 30, 2017
Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancersMarc B I Lobbes, Ingeborg J H Vriens, Annelotte C M van Bommel, et al.
The Lancet Regional Health. Europe|December 1, 2025
Frequency and survival of delayed breast cancer diagnosis in women participating at screening mammography in the Netherlands: a population-based studyLucien E M Duijm, Eline L van der Veer, Hermen C van Beek, et al.
Journal of Surgical Oncology|July 25, 2019
Predicting the extent of nodal involvement for node positive breast cancer patients: Development and validation of a novel toolIngrid van den Hoven, David van Klaveren, Nicole C Verheuvel, et al.
Pageof 16